secwatch.observer — SEC 8-K summary
======================================

Issuer:     CASTLE BIOSCIENCES INC (CSTL)
CIK:        0001447362
Form:       8-K
Filed at:   2022-06-03T23:59:59+00:00
Accession:  0001447362-22-000092
Event type: other_material
Sentiment:  neutral
Materiality: 0.25
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Castle Biosciences files updated pro forma financials for Cernostics acquisition
--------------------------------------------------------------------------------

- Pro forma net loss of $38.9M for FY2021, including $3.6M in transaction accounting adjustments.
- Pro forma revenue of $94.7M, reflecting Cernostics' $0.6M contribution.
- Pro forma diluted loss per share of $1.55, compared to Castle standalone $1.24.
- Pro forma operating loss of $47.7M, up from $40.1M standalone.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1447362/000144736222000092/0001447362-22-000092-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1447362/000144736222000092/cstl-20220603.htm
  HTML page:      https://secwatch.observer/filing/0001447362-22-000092

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer